Pharvaris advances an oral bradykinin B2 franchise with late-stage HAE programs, strong data, and major catalysts. Learn why ...
Expansion Adds U.S. FDA and EU Annex 1 Compliant GMP Capacity with High-Throughput Manufacturing Design and Advanced Automation by Q3 2026. "As more therapies advance to late-stage development, the ...
Oticara, an emerging pharmaceutical company advancing physician-delivered treatments for chronic rhinosinusitis (CRS), today announced that new late-breaking clinical data from its Phase 2 OT-007B ...
With the broader market “firmly past the early-cycle phase,” analysts see a bottoming process underway for Bitcoin.
~ Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD to be presented~ ~ Phase 3 data of the Launch-HTN ...
Precision BioSciences Presents Late-Breaking Phase 1 PBGENE-HBV Data at AASLD The Liver Meeting® Showing Safety, Tolerability and Cumulative, Dose-Dependent Antiviral Activity in First Three Cohorts ...
If you are a startup founder raising a venture round this year, you’ll get a lower valuation than you might have in 2021 or 2022. New data from CB Insights details that there have been sharp valuation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback